Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AKYA | US
0.10
3.73%
Healthcare
Medical Instruments & Supplies
30/06/2024
04/10/2024
2.78
2.57
2.81
2.50
Akoya Biosciences Inc. a life sciences technology company provides spatial biology solutions focused on transforming discovery and clinical research in North America the Asia Pacific Europe the Middle East and Africa. The company offers PhenoCycler instrument a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize analyze quantify and phenotype cells in situ in fresh frozen or FFPE tissue sections and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition the company offers analysis software partnerships ecosystem; inForm Tissue an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough Massachusetts.
View LessStrength based on increasing price with high volume
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
61.9%1 month
61.6%3 months
68.7%6 months
83.7%-
-
6.36
3.81
0.59
-6.83
1.94
-
-39.49M
130.39M
130.39M
-
-47.47
-
-1.50
-128.20
23.73
10.30
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.45
Range1M
0.69
Range3M
1.07
Rel. volume
1.51
Price X volume
589.33K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Lakeland Industries Inc | LAKE | Medical Instruments & Supplies | 19.25 | 142.38M | -1.43% | 77.62 | 35.09% |
TriSalus Life Sciences Inc. | TLSI | Medical Devices | 4.55 | 133.37M | 2.25% | 0.09 | -94.26% |
Myomo Inc | MYO | Medical Devices | 4.02 | 121.51M | 1.77% | n/a | 3.76% |
908 Devices Inc | MASS | Medical Devices | 3.5 | 121.30M | 3.24% | n/a | 3.58% |
Quipt Home Medical Corp. Common Shares | QIPT | Medical Devices | 2.8 | 120.65M | -0.36% | n/a | 0.00% |
KRMD | KRMD | Medical Instruments & Supplies | 2.62 | 120.14M | -1.13% | n/a | 21.21% |
Pro-Dex Inc | PDEX | Medical Instruments & Supplies | 31.04 | 105.57M | 0.91% | 45.57 | 43.89% |
Harvard Bioscience Inc | HBIO | Medical Instruments & Supplies | 2.4 | 104.67M | -6.25% | n/a | 61.64% |
Fonar Corporation | FONR | Medical Devices | 16.2 | 104.59M | 2.27% | 11.22 | 24.68% |
Sensus Healthcare Inc | SRTS | Medical Devices | 6.29 | 103.09M | 3.11% | 14.34 | 1.32% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14 | 87.66M | -1.27% | 14.62 | 7.10% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.02 | 57.65M | -4.67% | n/a | 268.43% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.89 | 19.79M | -2.50% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.0599 | 19.14M | -0.93% | n/a | 5.48% |
Rocky Mountain Chocolate Factory Inc | RMCF | Confectioners | 2.04 | 15.49M | 1.49% | n/a | 38.66% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.695 | 8.47M | -4.15% | n/a | 16.03% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -6.83 | 7.69 | Cheaper |
Ent. to Revenue | 1.94 | 64.13 | Cheaper |
PE Ratio | - | 50.95 | - |
Price to Book | 6.36 | 6.11 | Par |
Dividend Yield | - | 1.34 | - |
Std. Deviation (3M) | 68.69 | 55.82 | Riskier |
Debt to Equity | 3.81 | 0.86 | Expensive |
Debt to Assets | 0.59 | 0.26 | Expensive |
Market Cap | 130.39M | 9.95B | Emerging |